David Kenny Email

Director Service and Integration. . Echosens

Current Roles

Employees:
340
Revenue:
$85.3M
About
Empowering medical professionals to assess, diagnose and manage chronic liver diseases, everywhere, for simpler, faster and better patient care and liver health. In 2003, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the unique device using patented and validated VCTE™ for liver stiffness assessment, and CAP™ for steatosis quantification. FibroScan® device is recognized worldwide as the reference for non invasive liver diagnosis with more than 2,400 medical publications and 40 guidelines recommendations. We are working hand in hand with physicians, medical academic research, pharmaceutical companies for patient identification and monitoring in NAFLD/NASH. As patient education is a major issue, we have created the "myliverexam" website that provides information about the role of the liver and why it is vital to the global health.
Echosens Address
950 Winter Street
Paris, null
France
Echosens Email

Past Companies

EchosensDirector of Service and Integration.

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.